Ars TechnicaEN
The $15 billion ad-powered AI startup your doctor may already be using
OpenEvidence is booming despite questions about accuracy and ads.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
OpenEvidence is booming despite questions about accuracy and ads.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.